Format

Send to

Choose Destination
Dermatol Surg. 2009 Dec;35(12):1978-84. doi: 10.1111/j.1524-4725.2009.01312.x.

A five-patient satisfaction pilot study of calcium hydroxylapatite injection for treatment of aging hands.

Author information

1
Division of Dermatologic and Cosmetic Surgery, Department of Dermatology, The Mount Sinai Medical Center, New York, New York 10029-6574, USA.

Abstract

BACKGROUND:

The process of skin aging is not limited to the face but involves every part of the body, including the hands. A common manifestation of aging of the hands is the loss of volume, which occurs as the skin loses its subcutaneous fat. Injectable dermal fillers have surfaced as a popular method to address such deficiencies.

OBJECTIVES:

To report the use of calcium hydroxylapatite (CaHA) to address lost volume.

METHODS:

Five female subjects with soft tissue deficiency of the dorsa of the hands were enrolled at Mount Sinai Medical Center. A solution of CaHA with 2% lidocaine in amounts of 0.3 to 1.0 mL was injected interdigitally at each of three to five insertion sites; the sites were massaged and molded up to three times to ensure an optimal cosmetic end point. Subjects were seen for a follow-up visit after 1, 4, 16, and 24 weeks.

RESULTS:

With a single injection, all subjects reached their correction goals without requiring any touch-ups. At the 24-week visit, the subjects retained the filling effect, with no adverse events and high patient satisfaction.

CONCLUSION:

CaHA, a new, easily injectable, safe dermal filler, has emerged as an excellent option for soft tissue augmentation in aging hands.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center